Statins for primary prevention in older people do not cut mortality or CHD events, study findsBMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j2486 (Published 26 May 2017) Cite this as: BMJ 2017;357:j2486
- Susan Mayor
Treating older people who have moderate hyperlipidaemia and hypertension with statins for primary prevention of cardiovascular disease does not reduce mortality or coronary heart disease events, results from a post-hoc analysis of a large randomised trial have shown.1
Many older patients take statins for primary cardiovascular disease prevention. Although some evidence shows benefits from statins for secondary prevention in older people with cardiovascular diseases, limited data are available on the risks and benefits for primary prevention in this age group.
Researchers carried out a post-hoc analysis of data …